1. [fam‐] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification. Issue 12 (24th May 2019) Authors: Takegawa, Naoki; Tsurutani, Junji; Kawakami, Hisato; Yonesaka, Kimio; Kato, Ryoji; Haratani, Koji; Hayashi, Hidetoshi; Takeda, Masayuki; Nonagase, Yoshikane; Maenishi, Osamu; Nakagawa, Kazuhiko Journal: International journal of cancer Issue: Volume 145:Issue 12(2019) Page Start: 3414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alternating therapy with osimertinib and afatinib for treatment-naive patients with EGFR-mutated advanced non-small cell lung cancer: A single-group, open-label phase 2 trial (WJOG10818L). (June 2022) Authors: Hayashi, Hidetoshi; Yonesaka, Kimio; Nakamura, Atsushi; Fujimoto, Daichi; Azuma, Koichi; Sakata, Shinya; Tachihara, Motoko; Ikeda, Satoshi; Yokoyama, Toshihide; Hataji, Osamu; Yano, Yukihiro; Hirano, Katsuya; Daga, Haruko; Okada, Hideaki; Chiba, Yasutaka; Sakai, Kazuko; Nishio, Kazuto; Yamamoto, ... Journal: Lung cancer Issue: Volume 168(2022) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bevacizumab beyond disease progression after first‐line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non–small cell lung cancer (West Japan Oncology Group 5910L): An open‐label, randomized, phase 2 trial. Issue 7 (1st February 2016) Authors: Takeda, Masayuki; Yamanaka, Takeharu; Seto, Takashi; Hayashi, Hidetoshi; Azuma, Koichi; Okada, Morihito; Sugawara, Shunichi; Daga, Haruko; Hirashima, Tomonori; Yonesaka, Kimio; Urata, Yoshiko; Murakami, Haruyasu; Saito, Haruhiro; Kubo, Akihito; Sawa, Toshiyuki; Miyahara, Eiji; Nogami, Naoyuki; Na... Journal: Cancer Issue: Volume 122:Issue 7(2016) Page Start: 1050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Circulating heregulin level is associated with the efficacy of patritumab combined with erlotinib in patients with non-small cell lung cancer. (March 2017) Authors: Yonesaka, Kimio; Hirotani, Kenji; von Pawel, Joachim; Dediu, Mircea; Chen, Shuquan; Copigneaux, Catherine; Nakagawa, Kazuhiko Journal: Lung cancer Issue: Volume 105(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision‐Making for Patients with Advanced Solid Tumors. (6th January 2021) Authors: Takeda, Masayuki; Takahama, Takayuki; Sakai, Kazuko; Shimizu, Shigeki; Watanabe, Satomi; Kawakami, Hisato; Tanaka, Kaoru; Sato, Chihiro; Hayashi, Hidetoshi; Nonagase, Yoshikane; Yonesaka, Kimio; Takegawa, Naoki; Okuno, Tatsuya; Yoshida, Takeshi; Fumita, Soichi; Suzuki, Shinichiro; Haratani, Koji;... Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: e588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DS‐8201a, a new HER2‐targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2‐positive gastric cancer T‐DM1 resistance. Issue 8 (12th July 2017) Authors: Takegawa, Naoki; Nonagase, Yoshikane; Yonesaka, Kimio; Sakai, Kazuko; Maenishi, Osamu; Ogitani, Yusuke; Tamura, Takao; Nishio, Kazuto; Nakagawa, Kazuhiko; Tsurutani, Junji Journal: International journal of cancer Issue: Volume 141:Issue 8(2017:Oct. 15) Page Start: 1682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of coexisting gene mutations in EGFR-mutated non–small cell lung cancer before treatment on EGFR T790M mutation status after EGFR-TKIs. (January 2020) Authors: Takeda, Masayuki; Sakai, Kazuko; Hayashi, Hidetoshi; Tanaka, Kaoru; Haratani, Koji; Takahama, Takayuki; Kato, Ryoji; Yonesaka, Kimio; Nishio, Kazuto; Nakagawa, Kazuhiko Journal: Lung cancer Issue: Volume 139(2020) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mechanisms of primary and acquired resistance to immune checkpoint inhibitors in advanced non–small cell lung cancer: A multiplex immunohistochemistry–based single-cell analysis. (December 2022) Authors: Isomoto, Kohsuke; Haratani, Koji; Tsujikawa, Takahiro; Makutani, Yusuke; Kawakami, Hisato; Takeda, Masayuki; Yonesaka, Kimio; Tanaka, Kaoru; Iwasa, Tsutomu; Hayashi, Hidetoshi; Ito, Akihiko; Nishio, Kazuto; Nakagawa, Kazuhiko Journal: Lung cancer Issue: Volume 174(2022) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Mutational activation of the epidermal growth factor receptor down‐regulates major histocompatibility complex class I expression via the extracellular signal‐regulated kinase in non–small cell lung cancer. Issue 1 (27th November 2018) Authors: Watanabe, Satomi; Hayashi, Hidetoshi; Haratani, Koji; Shimizu, Shigeki; Tanizaki, Junko; Sakai, Kazuko; Kawakami, Hisato; Yonesaka, Kimio; Tsurutani, Junji; Togashi, Yosuke; Nishio, Kazuto; Ito, Akihiko; Nakagawa, Kazuhiko Journal: Cancer science Issue: Volume 110:Issue 1(2019) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacokinetics of amrubicin in lung cancer patients with impaired hepatic function. (2016) Authors: Ryuge, Shinichiro; Masuda, Noriyuki; Yamamoto, Nobuyuki; Takahashi, Toshiaki; Murakami, Haruyasu; Takeda, Koji; Daga, Haruko; Yonesaka, Kimio; Tsukuda, Hiroshi; Nakagawa, Kazuhiko; Tanaka, Kaoru; Kiura, Katsuyuki; Takigawa, Nagio; Hida, Toyoaki; Seto, Takashi; Yokoba, Masanori; Kudoh, Shinzoh; Ta... Journal: Cancer treatment and research communications Issue: Number 9(2016) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗